Is equity optimism overdone?
Equities are on a roll this year, fueled by hopes of a vaccine-led recovery and encouraging earnings numbers. But are valuations heading for a fall given seemingly ignored risks of vaccine problems, mistimed policy withdrawal and inflation threats?
- With valuations elevated, the risk-reward for equities appears balanced
- A bull case scenario for 2021 seems more likely
- Surging inflation and the reversal of fiscal and monetary stimulus seem to be the biggest downside risks for investors
- A stronger, quicker recovery than expected ranks among the top upside risks this year
- Focusing on an active approach to investing and allocating to “quality” companies seems preferable.
After rising as much as 6% in the first two months of the year, global equities have given up some gains so far in March. With negative surprises still potentially on the horizon, risk-reward seems balanced. However, surges in volatility likely lie ahead.
The final three months of last year are posting stronger earnings than expected. Over 80% of reporting companies beat consensus’ forecast in the US. Incredibly, fourth-quarter (Q4) earnings growth is on track to reach 3.5% rather than plunging by 8% as expected initially. Remember, comparator earnings in 2019 were unaffected by the COVID-19 outbreak. Additionally, anticipated earnings for the next twelve months are on the rise.
European earnings are more mixed, Q4 numbers shrinking by at least 15%. Most of the difference between American and European earnings for the quarter can be explained by diverging index composition, the latter being much more exposed to the energy and financial sectors and less to technology ones.
Enter the bull?
As a result of much stronger-than-expected Q4 earnings, equity markets’ fair value appears to be closer to our bull case scenario for 2021 (in the 3,900-4,000 range on the S&P 500). That said, this scenario assumes recovery through the year, backed by accommodative stimulus policies and successful COVID-19 vaccination campaign, cutting infection levels, in most of the developed world.
If any of the above assumptions do not deliver, the outcome is at risk of disappointing. Top of the worry pile is inflation, already on many investors’ minds. Recovery, base effects, stronger commodity prices and value-chain stress (like potential delays in supplying semiconductors due to unexpectedly strong demand) may see sharp rises in prices.
While a temporary surge in inflation is probably manageable, a sustained rise in prices would be a concern. Though moderate inflation (as opposed to deflation risk) may be welcome, persisting negative interest rates in Europe and low ones in America seem inappropriate for times when the inverse relationship between inflation and unemployment re-establishes itself.
Recalibrating monetary policy to prevent the economy from overheating may require central banks to adopt much tighter policy, possibly exerting downside pressure on equity valuations.
Outside of the risk of the pandemic becoming a feature of the world we live in for years to come, hitting recovery hopes, the other possible issue worth highlighting is around fiscal stimulus.
One of the biggest reasons why recovery from the pandemic shock is relatively quick is the bumper government bail outs offered during the crisis. However, as the debt burden and budget deficits balloon, at some point governments may have to pull the plug. That could spook financial markets and hinder growth.
Reversing stimulus measures would likely lead to a surge in bankruptcies, spike in the unemployment rate and bleaker outlook for companies. A knock-on effect could be to compromise the pace of the earnings recovery, hitting sentiment and asset prices. While such an outcome may trigger additional monetary support eventually, it would leave a mark.
On the upside
Much positive news already seems to be discounted by the market. That said, two particular upside risks seem worth keeping an eye on.
The first one relies on even stronger-than-anticipated earnings growth. After months of lockdown measures for consumers and spending being curtailed, pent-up demand might be significantly higher than initially thought.
Another upside risk could be a quicker return to normal than consensus anticipates, as suggested by January’s US retail sales performance. This appears an unlikely scenario in the short term. However, the combination of vaccines capable of fighting variants of the virus and better treatments for infected people could allow some badly affected industries (travel and leisure in particular) to recover ahead of schedule.
Active investing appeals
Upside at the index level appears limited for now. That said, investment opportunities can be tracked down, aided by likely elevated expectations, limited visibility and significant dispersion at both the sector and the stock level.
Wider dispersion in returns calls for a more active approach to investing, using stock picking to unearth opportunities in a world were beta might be less relevant. A bias to investing in “quality” companies, those with resilient free cash flow generation and attractive medium-term growth prospects, has appeal.
In addition, well diversified portfolios can help to mitigate the effects of known risks along with potentially extreme ones, so-called “black swan”, when they occur. This is why adopting a balanced portfolio approach seems preferable.
Investments can fall as well as rise in value. Your capital or the income generated from your investment may be at risk.
- Has been prepared by Barclays Private Bank and is provided for information purposes only
- Is not research nor a product of the Barclays Research department. Any views expressed in this communication may differ from those of the Barclays Research department
- All opinions and estimates are given as of the date of this communication and are subject to change. Barclays Private Bank is not obliged to inform recipients of this communication of any change to such opinions or estimates
- Is general in nature and does not take into account any specific investment objectives, financial situation or particular needs of any particular person
- Does not constitute an offer, an invitation or a recommendation to enter into any product or service and does not constitute investment advice, solicitation to buy or sell securities and/or a personal recommendation. Any entry into any product or service requires Barclays’ subsequent formal agreement which will be subject to internal approvals and execution of binding documents
- Is confidential and is for the benefit of the recipient. No part of it may be reproduced, distributed or transmitted without the prior written permission of Barclays Private Bank
- Has not been reviewed or approved by any regulatory authority.
Any past or simulated past performance including back-testing, modelling or scenario analysis, or future projections contained in this communication is no indication as to future performance. No representation is made as to the accuracy of the assumptions made in this communication, or completeness of, any modelling, scenario analysis or back-testing. The value of any investment may also fluctuate as a result of market changes.
Barclays is a full service bank. In the normal course of offering products and services, Barclays may act in several capacities and simultaneously, giving rise to potential conflicts of interest which may impact the performance of the products.
Where information in this communication has been obtained from third party sources, we believe those sources to be reliable but we do not guarantee the information’s accuracy and you should note that it may be incomplete or condensed.
Neither Barclays nor any of its directors, officers, employees, representatives or agents, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this communication or its contents or reliance on the information contained herein, except to the extent this would be prohibited by law or regulation. Law or regulation in certain countries may restrict the manner of distribution of this communication and the availability of the products and services, and persons who come into possession of this publication are required to inform themselves of and observe such restrictions.
You have sole responsibility for the management of your tax and legal affairs including making any applicable filings and payments and complying with any applicable laws and regulations. We have not and will not provide you with tax or legal advice and recommend that you obtain independent tax and legal advice tailored to your individual circumstances.
THIS COMMUNICATION IS PROVIDED FOR INFORMATION PURPOSES ONLY AND IS SUBJECT TO CHANGE. IT IS INDICATIVE ONLY AND IS NOT BINDING.